Last updated on May 2019

A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed iNO in Subjects With Pulmonary Fibrosis


Brief description of study

A phase 2b, randomized, double-blind, placebo-controlled dose escalation clinical study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) versus placebo in subjects with pulmonary fibrosis on long term oxygen therapy (Part 1 and Part 2).

Detailed Study Description

A phase 2b, randomized, double-blind, placebo-controlled dose escalation clinical study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) versus placebo in subjects with and without pulmonary hypertension associated with pulmonary fibrosis on long term oxygen therapy (Part 1 and Part 2).

Clinical Study Identifier: NCT03267108

Find a site near you

Start Over

University of Michigan

Ann Arbor, MI United States
  Connect »

Piedmont Healthcare

Austell, GA United States
  Connect »

The Lung Research Center, LLC

Chesterfield, MO United States
  Connect »

Temple University

Philadelphia, PA United States
  Connect »

National Jewish Health

Denver, CO United States
  Connect »

University of Miami

Miami, FL United States
  Connect »

Avanza Medical Research Center

Pensacola, FL United States
  Connect »

Emory University

Atlanta, GA United States
  Connect »

Daniel Dilling, MD

Chicago, IL United States
  Connect »

University of Cincinnati

Cincinnati, OH United States
  Connect »

University of Utah Health Sciences

Salt Lake City, UT United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.